A recent study from the University of Bologna, published in the journal Hypertension, has uncovered an important finding about women’s health and hypertension treatment.
Women who take beta-blockers for high blood pressure, without having any history of cardiovascular disease (CVD), face a higher risk of developing heart failure compared to men when they experience acute coronary syndrome.
Beta-blockers are a common medication prescribed to lower blood pressure and reduce the risk of heart problems. High blood pressure, or hypertension, is a leading cause of heart disease and stroke worldwide.
However, this study suggests that the effects of these medications may not be the same for men and women, particularly in severe heart conditions like acute coronary syndrome, where blood flow to the heart is suddenly reduced.
The researchers examined data from 13,764 adults in 12 European countries. All participants had hypertension but no prior cardiovascular disease.
The group was divided by gender and whether they were using beta-blockers. The results revealed some critical differences in outcomes between men and women.
Women taking beta-blockers showed a 4.6% higher risk of developing heart failure after being hospitalized for acute coronary syndrome compared to men.
For women who experienced a specific type of severe heart attack, called ST-segment elevation myocardial infarction (STEMI), the risk was even more pronounced. Women with STEMI were 6.1% more likely to develop heart failure than men with the same condition.
Another key finding was that men and women who were not on beta-blockers had nearly the same rate of heart failure. This suggests that the medication itself may contribute to the increased risk in women.
The study also highlighted the severe consequences of developing heart failure. Among patients who developed heart failure, the death rate was about seven times higher than for those who had a heart attack without heart failure.
While the exact reasons for this gender difference remain unclear, the researchers noted that hormone replacement therapy (HRT), commonly used by some women, might interact with beta-blockers and contribute to the risk.
However, this was not directly investigated in the study and requires further research. Other factors, such as differences in how men’s and women’s bodies process medications, may also play a role.
This finding points to the importance of tailored medical care, especially for women with high blood pressure. Doctors may need to reconsider the routine use of beta-blockers for women who have hypertension but no history of heart disease.
Instead, women might benefit from non-medication approaches, such as lifestyle changes. Managing blood pressure through a healthy diet, regular exercise, and reducing stress could help lower the risks without the potential side effects associated with some medications.
The study emphasizes the need for more research into gender-specific effects of heart disease treatments. As we learn more, it becomes clear that one-size-fits-all approaches to medicine might not work equally well for everyone.
For women at risk of heart problems, understanding these differences is a critical step toward better health outcomes.
If you are a woman managing high blood pressure, it may be a good idea to discuss these findings with your doctor to determine the best approach for your individual health needs.
If you care about blood pressure, please read studies about unhealthy habits that could increase high blood pressure risk, and people with severe high blood pressure should reduce coffee intake.
For more information about blood pressure, please see recent studies that early time-restricted eating could help improve blood pressure, and results showing plant-based foods could benefit people with high blood pressure.
Copyright © 2024 Knowridge Science Report. All rights reserved.
